Calocurb is a New Zealand-based startup that offers a unique approach to appetite and craving management. The company's slogan, "The only patented, natural GLP-1 activating nutraceutical," highlights its focus on natural, plant-based solutions. With its 100% plant-based supplement, Calocurb aims to provide consumers with a caffeine-free, vegan, and non-GMO approach to appetite control. The active ingredient in Calocurb is a distinctive extract from the hops flower, developed and clinically tested by leading New Zealand scientists from Plant & Food Research. This emphasizes the company's commitment to scientific research and development. The effectiveness of Calocurb is demonstrated by its ability to start working within just one hour, offering a practical solution to managing cravings. While specific details about the startup's founding date, industries, and last investment are not provided, the innovative nature of the product, coupled with its New Zealand headquarters, positions Calocurb within the rapidly growing health and wellness industry. The absence of information regarding the last investment and investors leaves room for potential interest from venture capitalists seeking opportunities in the natural health sector. As the market for plant-based supplements continues to expand, Calocurb presents an intriguing investment prospect due to its unique, patented product and scientific backing.
There is no investment information
No recent news or press coverage available for Calocurb.